(Q35634560)

9 August 2017

3 references

3 April 2019

11 July 2020

25 January 2021

Second primary breast cancer after Hodgkin's disease (English)

1 reference

radiation-induced neoplasms

9 August 2017

2 references

3 April 2019

11 July 2020

1 reference

11 July 2020

second primary neoplasm

1 reference

25 January 2021

A J Swerdlow

2

0 references

author name string

A Horwich

series ordinal

1

1 reference

PubMed ID

14735166

9 August 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

PubMed ID

14735166

British Journal of Cancer

9 August 2017

26 January 2004

3 references

3 April 2019

11 July 2020

25 January 2021

4 references

9 August 2017

3 April 2019

11 July 2020

25 January 2021

90

1 reference

9 August 2017

2

1 reference

9 August 2017

294-298

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6601499

9 August 2017

0 references

cites work

Molecular changes in second primary lung and breast cancers after therapy for Hodgkin's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409557

Increased risk of breast cancer following irradiation for Hodgkin's disease is not a result of ATM germline mutations

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409557

Treatment of Hodgkin's disease: results and current concepts of the German Hodgkin's Lymphoma Study Group

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409557

Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409557

Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409557

Breast cancer in women following supradiaphragmatic irradiation for Hodgkin's disease.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409557

Influence of more extensive radiotherapy and adjuvant chemotherapy on long-term outcome of early-stage Hodgkin's disease: a meta-analysis of 23 randomized trials involving 3,888 patients. International Hodgkin's Disease Collaborative Group.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409557

Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five Nordic countries. Association of the Nordic Cancer Registries and the Nordic Society of

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409557

Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409557

Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409557

Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute

12 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409557

12 July 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409557

The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409557

Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409557

Leukemia following Hodgkin's disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409557

Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409557

Breast carcinoma in women previously treated for Hodgkin disease: mammographic evaluation

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409557

Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409557

Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409557

Is breast MRI ever useful in a mammographic screening programme?

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409557

Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409557

Breast cancer screening in women previously treated for Hodgkin's disease: a prospective cohort study.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409557

Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409557

Can positron emission tomography with [(18)F]-fluorodeoxyglucose after first-line treatment distinguish Hodgkin's disease patients who need additional therapy from others in whom additional therapy would mean avoidable toxicity?

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409557

Second cancers following pediatric Hodgkin's disease.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409557

Late effects of treatment for childhood Hodgkin's disease

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409557

Breast cancer and other second neoplasms after childhood Hodgkin's disease

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409557

Breast cancer after treatment of Hodgkin's disease.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409557

Mortality in a cohort of women given X-ray therapy for metropathia haemorrhagica.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409557

Alternating drug combinations in the treatment of advanced Hodgkin's disease

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409557

Rare variants of ATM and risk for Hodgkin's disease and radiation-associated breast cancers

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409557

Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin’s Disease: A Population-Based Evaluation Over 25 Years

25 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601499

Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601499

Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409557

The incidence of breast cancer following mantle field radiation therapy as a function of dose and technique

15 November 2018

1 reference

12 December 2020

Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study

1 reference

12 December 2020

Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors

1 reference

12 December 2020

Long-term cause-specific mortality of patients treated for Hodgkin's disease

1 reference

12 December 2020

Risk of second cancers after treatment for Hodgkin's disease

1 reference

12 December 2020

Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study

1 reference

12 December 2020

Second cancers after Hodgkin's disease in childhood

1 reference

12 December 2020

Breast cancer and radiotherapy in ataxia-telangiectasia heterozygote

1 reference

12 December 2020

Family history of patients with breast cancer after treatment of Hodgkin's disease in childhood. Late Effects Study Group

1 reference

12 December 2020

High risk of breast carcinoma after irradiation of young women with Hodgkin's disease

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6601499

1 reference

9 August 2017

1 reference

9 August 2017

1 reference

PubMed ID

14735166